Recently, calpain has been implicated in the production of toxic fragments in two other diseases besides Alzheimer's disease: α-synuclein in Parkinson's disease [23] and huntingtin in Huntington's Disease [21], [22], [36]. This evidence concerns the gene HTT and Huntington disease.